Cargando…
Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation
ABCC8 and KCJN11 mutations cause the most severe diazoxide-resistant forms of congenital hyperinsulinism (CHI). Somatostatin analogues are considered as secondline treatment in diazoxide-unresponsive cases. Current treatment protocols include the first-generation somatostatin analogue octreotide, al...
Autores principales: | Mooij, Christiaan F., Tacke, Carline E., van Albada, Mirjam E., Barthlen, Winfried, Bikker, Hennie, Mohnike, Klaus, Oomen, Matthijs W.N., van Trotsenburg, A.S. Paul, Zwaveling-Soonawala, Nitash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Pediatric Endocrinology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749021/ https://www.ncbi.nlm.nih.gov/pubmed/33971706 http://dx.doi.org/10.6065/apem.2142010.005 |
Ejemplares similares
-
Integration of genomic analysis and transcript expression of ABCC8 and KCNJ11 in focal form of congenital hyperinsulinism
por: Wieland, Ilse, et al.
Publicado: (2022) -
Low free thyroxine and normal thyroid-stimulating hormone in infants and children: possible causes and diagnostic work-up
por: Lauffer, Peter, et al.
Publicado: (2021) -
The Effect of Pre-Thyroidectomy Calcitriol Prophylaxis on Post-Thyroidectomy Hypocalcaemia in Children
por: Vendrig, Lisanne M., et al.
Publicado: (2022) -
Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
por: Boelen, Anita, et al.
Publicado: (2023) -
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation
por: Zwaveling-Soonawala, N., et al.
Publicado: (2010)